QA: Indaptus Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001857044_2023_Indaptus_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001857044, Indaptus Therapeutics Inc.

  xvar xval
0 AssetsCurrent 27,244,242
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,019
3 remainder_Assets 817,545
4 LiabilitiesCurrent 3,433,341
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,586,249
9 ResearchAndDevelopmentExpense 6,324,657
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 588,108
13 remainder_ComprehensiveNetIncome 96,434
  yvar yval
0 Assets 28,063,806
1 Liabilities 3,433,341
2 Expenses 14,910,906
3 Revenues 0
4 StockholdersEquity 24,630,465
5 NetIncome -14,322,798
6 ComprehensiveNetIncome -14,274,581
7 BaseVar 23,546,298
8 EconomicCapitalRatio 1.78

Edgar->Model Mapping

Feature Distribution

Change over Time